Business Description
Establishment Labs Holdings Inc
NAICS : 339112
SIC : 5047
ISIN : VGG312491084
Total Employee Number:
1,004Description
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.04 | |||||
Debt-to-Equity | 17.86 | |||||
Debt-to-EBITDA | -15.6 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.64 | |||||
Beneish M-Score | -2.37 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.5 | |||||
3-Year EBITDA Growth Rate | 31.3 | |||||
3-Year EPS without NRI Growth Rate | 11.6 | |||||
3-Year FCF Growth Rate | 18 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 25.5 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 77.7 | |||||
9-Day RSI | 73.27 | |||||
14-Day RSI | 70.37 | |||||
3-1 Month Momentum % | 23.17 | |||||
6-1 Month Momentum % | 7.2 | |||||
12-1 Month Momentum % | 70.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.96 | |||||
Quick Ratio | 1.91 | |||||
Cash Ratio | 0.82 | |||||
Days Inventory | 473.14 | |||||
Days Sales Outstanding | 114.26 | |||||
Days Payable | 239.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -1.64 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 70.06 | |||||
Operating Margin % | -12.45 | |||||
Net Margin % | -19.05 | |||||
EBITDA Margin % | -7.37 | |||||
FCF Margin % | -18.35 | |||||
OCF Margin % | -15.02 | |||||
ROE % | -188.51 | |||||
ROA % | -12.79 | |||||
ROIC % | -11.33 | |||||
3-Year ROIIC % | 5.05 | |||||
ROC (Joel Greenblatt) % | -13.49 | |||||
ROCE % | -9.38 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 11.78 | |||||
PB Ratio | 183.12 | |||||
Price-to-Tangible-Book | 610.6 | |||||
EV-to-EBIT | -116.42 | |||||
EV-to-EBITDA | -170.82 | |||||
EV-to-Forward-EBITDA | 2423.35 | |||||
EV-to-Revenue | 12.59 | |||||
EV-to-Forward-Revenue | 16.88 | |||||
EV-to-FCF | -68.61 | |||||
Price-to-GF-Value | 1.49 | |||||
Earnings Yield (Greenblatt) % | -0.86 | |||||
FCF Yield % | -1.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ESTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Establishment Labs Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 229.576 | ||
| EPS (TTM) ($) | -1.49 | ||
| Beta | 1.3994 | ||
| 3-Year Sharpe Ratio | 0.37 | ||
| 3-Year Sortino Ratio | 0.6 | ||
| Volatility % | 62.69 | ||
| 14-Day RSI | 70.37 | ||
| 14-Day ATR ($) | 4.111758 | ||
| 20-Day SMA ($) | 84.5345 | ||
| 12-1 Month Momentum % | 70.67 | ||
| 52-Week Range ($) | 33.35 - 92.835 | ||
| Shares Outstanding (Mil) | 29.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Establishment Labs Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Establishment Labs Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-05 08:30 | In 122 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 121 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 08:30 | In 32 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 31 days | ||
| General meeting for 2026 | 2026-05-22 13:00 | 71.23 (+1.86%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 08:30 | 70.99 (+0.24%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 70.99 (+0.24%) | ||
| TD Cowen\'s 46th Annual Health Care Conference | 2026-03-02 09:10 | 78.70 (+3.47%) | ||
| Annual report for 2025 | 2026-02-27 | 77.15 (-1.09%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-24 08:30 | 74.96 (-1.06%) |
Show
Entries
Establishment Labs Holdings Inc Frequently Asked Questions
What is Establishment Labs Holdings Inc(ESTA)'s stock price today?
The current price of ESTA is $91.59. The 52 week high of ESTA is $92.84 and 52 week low is $33.35.
When is next earnings date of Establishment Labs Holdings Inc(ESTA)?
The next earnings date of Establishment Labs Holdings Inc(ESTA) is 2026-08-07 Est..
Does Establishment Labs Holdings Inc(ESTA) pay dividends? If so, how much?
Establishment Labs Holdings Inc(ESTA) does not pay dividend.
Guru Commentaries on NAS:ESTA
No articles.
Press Release
Articles on Establishment Labs Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers